Golvatinib |
Inhibitor of MET, KDR
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| MET |
| |
| KDR |
|
Inhibitor
up to 5 uM
Selectivity
Potency Cellular
In Vitro
MET
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1111/j.1349-7006.2009.01343.x
KDR
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1111/j.1349-7006.2009.01343.x
In Vivo Validations
Orthogonal Probes def
abozantinib
Chemical Information
| Molecular Formula | C33H37F2N7O4 |
| SMILEs | CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1 |
| InChI | InChI=1S/C33H37F2N7O4/c1-40-16-18-41(19-17-40)24-9-14-42(15-10-24)32(45)39-29-21-26(8-13-36-29)46-25-6-7-28(27(35)20-25)38-31(44)33(11-12-33)30(43)37-23-4-2-22(34)3-5-23/h2-8,13,20-21,24H,9-12,14-19H2,1H3,(H,37,43)(H,38,44)(H,36,39,45) |
| Molecular weight | 633.29 Da |
| AlogP | 4.7532 |
| HBond acceptors | 11 |
| HBond donors | 3 |
| Atoms | 83 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.